11Indexed trials
drug · Product Intelligence
Cisplatin
Pipeline Intelligence
Cisplatin: 11 indexed trials, 3 sponsors; 0 linked Orange Book patents and 10 FDA-linked events where matched.
3Sponsors
0Orange Book patent links
10FDA-linked events
Development evidence
NCT02964013Merck Sharp & Dohme LLC · parkinsonsPHASE1
NCT03066778Merck Sharp & Dohme LLC · parkinsonsPHASE3
NCT03221426Merck Sharp & Dohme LLC · parkinsonsPHASE3
NCT03348904Incyte Corporation · parkinsonsPHASE3
NCT03358472Incyte Corporation · parkinsonsPHASE3
NCT03615326Merck Sharp & Dohme LLC · parkinsonsPHASE3
NCT04003636Merck Sharp & Dohme LLC · parkinsonsPHASE3
NCT06647563Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · parkinsonsPHASE3
NCT06788912Merck Sharp & Dohme LLC · parkinsonsPHASE2
NCT06952504Merck Sharp & Dohme LLC · parkinsonsPHASE3
NCT07216703Merck Sharp & Dohme LLC · parkinsonsPHASE3
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALCISPLATIN · 2024-05-10
FDA_APPROVALCISPLATIN · 2017-03-17
FDA_APPROVALCISPLATIN · 2015-08-18
FDA_APPROVALCISPLATIN · 2012-04-18
FDA_APPROVALCISPLATIN · 2000-11-14
FDA_APPROVALCISPLATIN · 2000-11-07
FDA_APPROVALCISPLATIN · 2000-05-16
FDA_APPROVALCISPLATIN · 2000-05-16
FDA_APPROVALCISPLATIN · 1999-07-16
FDA_APPROVALPLATINOL ·
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.